Press Releases

WILMINGTON, Del., March 28, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is hosting an Innovation Day for analysts and investors at the company’s Bridgewater, New Jersey facility, Thursday, May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's

WILMINGTON, Del. March 24, 2025 – Ashland Inc. (NYSE: ASE) is harnessing its innovative technologies as a leader in rheology modifiers, broadening its coatings and specialty markets portfolio with new products that respond to the demand for optimal performance and supporting sustainability with

Wilmington, Del., March 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has completed the sale of its Avoca business to Mane effective March 14, 2025. Financial terms of the transaction were not disclosed. The Avoca business supplies sclareolide, a fragrance fixative,

Wilmington, Del., March 13, 2025 – Ashland has launched their iSolveSM customer portal for  on-demand information to support crop care customers. The portal enables easy access to robust information about the company’s crop care ingredients and other important related business material including

Wilmington, Del., March 3, 2025 – Ashland is increasing prices on 1-4-Butanediol (BDO) and several solvents products as indicated below: Product Amount of increase 1-4 butanediol (BDO) Min $0.33 per kg (equivalent in euro) gamma-butyrolactone (BLO ® ) Min $0.33 per kg (equivalent in euro)

WILMINGTON, Del., February 14, 2025, – Ashland, a premier specialty materials company, and leader in gafchromic™ film based advanced dosimetry solutions, is pleased to announce the launch of its in-vivo dosimetry system, designed to support treatment accuracy in radiation therapy.

WILMINGTON, Del., February 5, 2025, – Ashland, a premier specialty materials company, is pleased to announce compliance with the upcoming for Lactide (or lactic acid) and Glycolide (or glycolic acid) (LG) polymer USP-NF monographs. The announcement came during a joint webinar with Ashland and

Sales of $405 million, down 14 percent from the prior-year quarter Previously announced carboxymethylcellulose (CMC), methylcellulose (MC) and nutraceuticals portfolio optimization initiatives (collectively, “Portfolio Optimization”) reduced overall sales by approximately $50 million or 11 percent

WILMINGTON, Del., Jan. 20, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock. The dividend is payable on March 15, 2025, to stockholders of record at the close of business on

WILMINGTON, Del., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its first-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, January 28, 2025. The company’s live webcast with securities analysts will include an executive summary